A detailed history of Cullen/Frost Bankers, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 21,673 shares of CRL stock, worth $3.54 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
21,673
Previous 25,048 13.47%
Holding current value
$3.54 Million
Previous $5.17 Million 17.49%
% of portfolio
0.06%
Previous 0.08%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$187.96 - $245.29 $634,365 - $827,853
-3,375 Reduced 13.47%
21,673 $4.27 Million
Q2 2024

Aug 05, 2024

SELL
$206.39 - $268.73 $26,005 - $33,859
-126 Reduced 0.5%
25,048 $5.17 Million
Q1 2024

May 10, 2024

BUY
$203.52 - $273.43 $2,238 - $3,007
11 Added 0.04%
25,174 $6.82 Million
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $111,544 - $161,933
-678 Reduced 2.62%
25,163 $5.95 Million
Q3 2023

Nov 02, 2023

BUY
$194.44 - $217.61 $146,996 - $164,513
756 Added 3.01%
25,841 $5.06 Million
Q2 2023

Aug 04, 2023

BUY
$183.71 - $210.25 $180,403 - $206,465
982 Added 4.07%
25,085 $5.27 Million
Q1 2023

May 05, 2023

BUY
$191.89 - $259.92 $3.97 Million - $5.37 Million
20,671 Added 602.3%
24,103 $4.86 Million
Q4 2022

Feb 13, 2023

SELL
$197.11 - $250.07 $176,216 - $223,562
-894 Reduced 20.67%
3,432 $747,000
Q3 2022

Nov 07, 2022

SELL
$182.44 - $250.54 $52,360 - $71,904
-287 Reduced 6.22%
4,326 $851,000
Q2 2022

Aug 05, 2022

BUY
$204.13 - $302.4 $89,000 - $131,846
436 Added 10.44%
4,613 $987,000
Q1 2022

May 09, 2022

BUY
$255.51 - $362.11 $131,587 - $186,486
515 Added 14.06%
4,177 $1.19 Million
Q4 2021

Feb 07, 2022

SELL
$351.38 - $448.68 $439,927 - $561,747
-1,252 Reduced 25.48%
3,662 $1.38 Million
Q3 2021

Nov 04, 2021

SELL
$372.64 - $458.3 $9,688 - $11,915
-26 Reduced 0.53%
4,914 $2.03 Million
Q2 2021

Aug 05, 2021

BUY
$294.17 - $371.65 $93,546 - $118,184
318 Added 6.88%
4,940 $1.83 Million
Q1 2021

May 05, 2021

SELL
$249.67 - $299.48 $13,232 - $15,872
-53 Reduced 1.13%
4,622 $1.34 Million
Q4 2020

Feb 08, 2021

SELL
$222.0 - $252.62 $78,810 - $89,680
-355 Reduced 7.06%
4,675 $1.17 Million
Q3 2020

Nov 05, 2020

SELL
$175.56 - $226.45 $14,571 - $18,795
-83 Reduced 1.62%
5,030 $1.14 Million
Q2 2020

Aug 05, 2020

BUY
$118.84 - $189.72 $568,887 - $908,189
4,787 Added 1468.4%
5,113 $891,000
Q1 2020

May 01, 2020

BUY
$98.9 - $178.34 $10,186 - $18,369
103 Added 46.19%
326 $41,000
Q4 2019

Feb 06, 2020

BUY
$126.05 - $152.76 $28,109 - $34,065
223 New
223 $34,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.3B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.